Accès gratuit
| Numéro |
Therapie
Volume 67, Numéro 4, Juillet-Août 2012
|
|
|---|---|---|
| Page(s) | 295 - 300 | |
| Section | Évaluation du médicament / Drug Evaluation | |
| DOI | https://doi.org/10.2515/therapie/2012047 | |
| Publié en ligne | 1 novembre 2012 | |
- World Alzheimer Report 2010. http://www.alz.co.uk/ [Google Scholar]
- Mangialasche F, Solomon A, Winblad B, et al. Alzheimer’s disease: clinical trials and drug development. Lancet Neurol 2010; 9(7): 702-16 [CrossRef] [PubMed] [Google Scholar]
- Alzheimer Research Forum. http://www.alzforum.org/ [Google Scholar]
- www.pharmacog.org [Google Scholar]
- Weiner MW, Veitch DP, Aisen PS, et al. The Alzheimer’s disease neuroimaging initiative: a review of papers published since its inception. Alzheimers Dement 2012 Feb; 8(1 Suppl): S1-68 [Google Scholar]
- Barratt RA, Bowens SL, McCune SK, et al. The critical path initiative: leveraging collaborations to enhance regulatory science. Clin Pharmacol Ther 2012 Mar; 91(3): 380-3 [CrossRef] [PubMed] [Google Scholar]
- http://www-dsv.cea.fr/dsv/instituts/institut-d-imagerie-biomedicale-i2bm/services/neurospin-neurospin [Google Scholar]
- http://icm-institute.org/ [Google Scholar]